| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Absence of ectopic epithelial inclusions in 3,904 axillary lymph nodes examined in sentinel technique
|
Iken, Sonja
|
|
2011
|
132 |
2 |
p. 621-624
|
article
|
| 2 |
A cost-benefit analysis of bevacizumab in combination with paclitaxel in the first-line treatment of patients with metastatic breast cancer
|
Montero, Alberto J.
|
|
2011
|
132 |
2 |
p. 747-751
|
article
|
| 3 |
A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population
|
Sueta, Aiko
|
|
2011
|
132 |
2 |
p. 711-721
|
article
|
| 4 |
A prognostic model for lymph node-negative breast cancer patients based on the integration of proliferation and immunity
|
Oh, Ensel
|
|
2011
|
132 |
2 |
p. 499-509
|
article
|
| 5 |
A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance
|
Meads, Catherine
|
|
2011
|
132 |
2 |
p. 365-377
|
article
|
| 6 |
Bone metastasis in a novel breast cancer mouse model containing human breast and human bone
|
Xia, Tian-Song
|
|
2011
|
132 |
2 |
p. 471-486
|
article
|
| 7 |
Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation
|
Chung, Karine
|
|
2011
|
132 |
2 |
p. 653-660
|
article
|
| 8 |
Cadherin–catenin complex dissociation in lobular neoplasia of the breast
|
Morrogh, Mary
|
|
2011
|
132 |
2 |
p. 641-652
|
article
|
| 9 |
Comparison of two nomograms to predict pathologic complete responses to neoadjuvant chemotherapy for breast cancer: evidence that HER2-positive tumors need specific predictors
|
Frati, Albane
|
|
2011
|
132 |
2 |
p. 601-607
|
article
|
| 10 |
Effect of baseline serum vitamin D levels on aromatase inhibitors induced musculoskeletal symptoms: results from the IBIS-II, chemoprevention study using anastrozole
|
Singh, Shalini
|
|
2011
|
132 |
2 |
p. 625-629
|
article
|
| 11 |
ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer
|
Jensen, Jeanette Dupont
|
|
2011
|
132 |
2 |
p. 511-521
|
article
|
| 12 |
Estrogen receptor-α and sex steroid hormones regulate Toll-like receptor-9 expression and invasive function in human breast cancer cells
|
Sandholm, Jouko
|
|
2011
|
132 |
2 |
p. 411-419
|
article
|
| 13 |
Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes
|
Nagel, Jord H. A.
|
|
2011
|
132 |
2 |
p. 439-448
|
article
|
| 14 |
Genetic variants at chromosome 9p21, 10p15 and 10q22 and breast cancer susceptibility in a Chinese population
|
Chen, Jiaping
|
|
2011
|
132 |
2 |
p. 741-746
|
article
|
| 15 |
Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse
|
Harrell, J. Chuck
|
|
2011
|
132 |
2 |
p. 523-535
|
article
|
| 16 |
Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression
|
Alford, Sharon Hensley
|
|
2011
|
132 |
2 |
p. 429-437
|
article
|
| 17 |
In situ detection of HER2:HER2 and HER2:HER3 protein–protein interactions demonstrates prognostic significance in early breast cancer
|
Spears, Melanie
|
|
2011
|
132 |
2 |
p. 463-470
|
article
|
| 18 |
KX-01, a novel Src kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor α positive breast cancer
|
Anbalagan, Muralidharan
|
|
2011
|
132 |
2 |
p. 391-409
|
article
|
| 19 |
LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome
|
Stebbing, Justin
|
|
2011
|
132 |
2 |
p. 537-544
|
article
|
| 20 |
Melatonin pathway genes and breast cancer risk among Chinese women
|
Deming, Sandra L.
|
|
2011
|
132 |
2 |
p. 693-699
|
article
|
| 21 |
Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts
|
Knower, Kevin C.
|
|
2012
|
132 |
2 |
p. 765-771
|
article
|
| 22 |
Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer
|
Speyer, Cecilia L.
|
|
2011
|
132 |
2 |
p. 565-573
|
article
|
| 23 |
Multilevel determinants of breast cancer survival: association with geographic remoteness and area-level socioeconomic disadvantage
|
Dasgupta, Paramita
|
|
2011
|
132 |
2 |
p. 701-710
|
article
|
| 24 |
Optimal outcomes for liver-dominant metastatic breast cancer with transarterial chemoembolization with drug-eluting beads loaded with doxorubicin
|
Martin, Robert C. G.
|
|
2011
|
132 |
2 |
p. 753-763
|
article
|
| 25 |
Outcomes of a weight loss intervention among rural breast cancer survivors
|
Befort, Christie A.
|
|
2011
|
132 |
2 |
p. 631-639
|
article
|
| 26 |
Phase II trial of preoperative paclitaxel, gemcitabine, and trastuzumab combination therapy in HER2 positive stage II/III breast cancer: The Korean Cancer Study Group BR 07-01
|
Im, Seock-Ah
|
|
2011
|
132 |
2 |
p. 589-600
|
article
|
| 27 |
Phenocopy breast cancer rates in Israeli BRCA1BRCA2 mutation carrier families: is the risk increased in non-carriers?
|
Bernholtz, Shiri
|
|
2011
|
132 |
2 |
p. 669-673
|
article
|
| 28 |
Pilot and feasibility study: prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways
|
Ibarra-Drendall, Catherine
|
|
2011
|
132 |
2 |
p. 487-498
|
article
|
| 29 |
Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial
|
Gogas, Helen
|
|
2011
|
132 |
2 |
p. 609-619
|
article
|
| 30 |
Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project
|
Kwan, Marilyn L.
|
|
2011
|
132 |
2 |
p. 729-739
|
article
|
| 31 |
Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH
|
Joosse, Simon A.
|
|
2010
|
132 |
2 |
p. 379-389
|
article
|
| 32 |
Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer
|
Zhang, Juan
|
|
2011
|
132 |
2 |
p. 421-428
|
article
|
| 33 |
Risk of breast cancer in families of multiple affected women and men
|
Bevier, Melanie
|
|
2011
|
132 |
2 |
p. 723-728
|
article
|
| 34 |
Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study
|
Guglielmini, Pamela
|
|
2011
|
132 |
2 |
p. 661-668
|
article
|
| 35 |
Surgical treatment of early stage breast cancer in elderly: an international comparison
|
Kiderlen, M.
|
|
2011
|
132 |
2 |
p. 675-682
|
article
|
| 36 |
Targeting low molecular weight cyclin E (LMW-E) in breast cancer
|
Nanos-Webb, Angela
|
|
2011
|
132 |
2 |
p. 575-588
|
article
|
| 37 |
The anatomy of fluid-yielding ducts in breast cancer
|
Twelves, Dominique
|
|
2011
|
132 |
2 |
p. 555-564
|
article
|
| 38 |
The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells
|
Ligumsky, Hagai
|
|
2011
|
132 |
2 |
p. 449-461
|
article
|
| 39 |
The prognostic significance of B lymphocytes in invasive carcinoma of the breast
|
Mahmoud, S. M. A.
|
|
2011
|
132 |
2 |
p. 545-553
|
article
|
| 40 |
The role of antiresorptive therapies in improving patient care in early and metastatic breast cancer
|
Candelaria-Quintana, Dulcinea
|
|
2011
|
132 |
2 |
p. 355-363
|
article
|
| 41 |
Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U.S.
|
Rollison, Dana E.
|
|
2011
|
132 |
2 |
p. 683-691
|
article
|
Journal description